<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MD</journal-id>
<journal-title>Marine Drugs</journal-title>
<abbrev-journal-title>MD</abbrev-journal-title>
<issn pub-type="epub">1660-3397</issn>
<publisher>
<publisher-name>Molecular Diversity Preservation International</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3390/md9050772</article-id>
<article-id pub-id-type="publisher-id">marinedrugs-09-00772</article-id>
<article-categories>
<subj-group>
<subject>Article</subject></subj-group></article-categories>
<title-group>
<article-title>Genetic Approach for the Fast Discovery of Phenazine Producing Bacteria</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Schneemann</surname><given-names>Imke</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Wiese</surname><given-names>Jutta</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Kunz</surname><given-names>Anna Lena</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>Imhoff</surname><given-names>Johannes F.</given-names></name><xref ref-type="corresp" rid="c1-marinedrugs-09-00772"><sup>*</sup></xref></contrib>
<aff id="af1-marinedrugs-09-00772">Kieler Wirkstoff-Zentrum (KiWiZ) am Leibniz-Institut für Meereswissenschaften (IFM-GEOMAR), Am Kiel-Kanal 44, 24106 Kiel, Germany; E-Mails: <email>ischneemann@ifm-geomar.de</email> (I.S.); <email>jwiese@ifm-geomar.de</email> (J.W.); <email>akunz@ifm-geomar.de</email> (A.L.K.)</aff></contrib-group>
<author-notes>
<corresp id="c1-marinedrugs-09-00772">
<label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>jimhoff@ifm-geomar.de</email>; Tel.: +49-431-600-4450; Fax: +49-431-600-4452.</corresp></author-notes>
<pub-date pub-type="collection">
<year>2011</year></pub-date>
<pub-date pub-type="epub">
<day>9</day>
<month>5</month>
<year>2011</year></pub-date>
<volume>9</volume>
<issue>5</issue>
<fpage>772</fpage>
<lpage>789</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>2</month>
<year>2011</year></date>
<date date-type="rev-recd">
<day>1</day>
<month>4</month>
<year>2011</year></date>
<date date-type="accepted">
<day>29</day>
<month>4</month>
<year>2011</year></date></history>
<permissions>
<copyright-statement>© 2011 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
<copyright-year>2011</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p></license></permissions>
<abstract>
<p>A fast and efficient approach was established to identify bacteria possessing the potential to biosynthesize phenazines, which are of special interest regarding their antimicrobial activities. Sequences of <italic>phz</italic>E genes, which are part of the phenazine biosynthetic pathway, were used to design one universal primer system and to analyze the ability of bacteria to produce phenazine. Diverse bacteria from different marine habitats and belonging to six major phylogenetic lines were investigated. Bacteria exhibiting <italic>phz</italic>E gene fragments affiliated to <italic>Firmicutes</italic>, <italic>Alpha-</italic> and <italic>Gammaproteobacteria</italic>, and <italic>Actinobacteria</italic>. Thus, these are the first primers for amplifying gene fragments from <italic>Firmicutes</italic> and <italic>Alphaproteobacteria</italic>. The genetic potential for phenazine production was shown for four type strains belonging to the genera <italic>Streptomyces</italic> and <italic>Pseudomonas</italic> as well as for 13 environmental isolates from marine habitats. For the first time, the genetic ability of phenazine biosynthesis was verified by analyzing the metabolite pattern of all PCR-positive strains via HPLC-UV/MS. Phenazine production was demonstrated for the type strains known to produce endophenazines, 2-hydroxy-phenazine, phenazine-1-carboxylic acid, phenazine-1,6-dicarboxylic acid, and chlororaphin as well as for members of marine <italic>Actinobacteria</italic>. Interestingly, a number of unidentified phenazines possibly represent new phenazine structures.</p></abstract>
<kwd-group>
<kwd>phenazine</kwd>
<kwd><italic>Actinobacteria</italic></kwd>
<kwd>oligonucleotides</kwd>
<kwd>HPLC-UV/MS</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Nature is a profitable source of pharmaceutically active substances covering the whole range of biological activities such as antimicrobial, antitumoral, antiparasitic or immunosuppressive [<xref ref-type="bibr" rid="b1-marinedrugs-09-00772">1</xref>,<xref ref-type="bibr" rid="b2-marinedrugs-09-00772">2</xref>]. Various natural products or natural product-derived compounds have been approved as drugs or are undergoing clinical evaluation and registration [<xref ref-type="bibr" rid="b2-marinedrugs-09-00772">2</xref>,<xref ref-type="bibr" rid="b3-marinedrugs-09-00772">3</xref>]. Because the rediscovery rate of already known substances in standard screening approaches is high, new strategies are urgently needed. Genetic approaches for the detection of secondary metabolite pathways are promising tools for the selection of biosynthetically talented microorganisms. So far, main targets in this respect were genes encoding for polyketide synthases (PKSs) or non-ribosomal peptide synthetases (NRPSs) [<xref ref-type="bibr" rid="b4-marinedrugs-09-00772">4</xref>,<xref ref-type="bibr" rid="b5-marinedrugs-09-00772">5</xref>]. By focusing on polyketides and non-ribosomal peptides other interesting compound classes such as phenazines have been neglected so far. Phenazines of natural or synthetic origin turned out to be good drug candidates and therefore are promising secondary metabolites [<xref ref-type="bibr" rid="b6-marinedrugs-09-00772">6</xref>]. They are heterocyclic, nitrogenous compounds that are substituted at different sites of the core ring system and therefore display a wide range of structural derivatives and biological activities. More than 100 biologically active (antibacterial, antifungal, antiviral, antitumor) phenazines from natural origin are known to date, synthesized mainly by <italic>Pseudomonas</italic> and <italic>Streptomyces</italic> species [<xref ref-type="bibr" rid="b7-marinedrugs-09-00772">7</xref>]. Phenazines produced by the root-colonizing <italic>Pseudomonas fluorescens</italic> 2–79 and <italic>Pseudomonas aureofaciens</italic> 30–84 are good examples for congeners with promising biological activity, in this case inhibiting several fungal plant pathogens [<xref ref-type="bibr" rid="b8-marinedrugs-09-00772">8</xref>]. An economically successful phenazine is clofazimine (Lamprene®, Novartis), first described in 1957 which was established as an antileprosy agent and exerts anti-inflammatory properties in controlling <italic>erythema nodosum leprosum</italic> reactions (Official FDA Drug label) [<xref ref-type="bibr" rid="b6-marinedrugs-09-00772">6</xref>] as well as other antimicrobial activities [<xref ref-type="bibr" rid="b9-marinedrugs-09-00772">9</xref>–<xref ref-type="bibr" rid="b11-marinedrugs-09-00772">11</xref>]. Clofazimine is a synthetic phenazine analogue belonging to the riminophenazines, a group of compounds which was originally discovered in lichens [<xref ref-type="bibr" rid="b12-marinedrugs-09-00772">12</xref>,<xref ref-type="bibr" rid="b13-marinedrugs-09-00772">13</xref>]. Another phenazine, bis(phenazine-1-carboxamide), acts as a potent cytotoxin and represents an interesting class of dual topoisomerase I/II directed anticancer drugs [<xref ref-type="bibr" rid="b14-marinedrugs-09-00772">14</xref>].</p>
<p>Although principal parts of the phenazine biosynthesis (<xref ref-type="fig" rid="f1-marinedrugs-09-00772">Figure 1</xref>) and their genetics are known [<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>,<xref ref-type="bibr" rid="b16-marinedrugs-09-00772">16</xref>], there are still gaps in our knowledge and the phenazine pathway is still hypothetical [<xref ref-type="bibr" rid="b17-marinedrugs-09-00772">17</xref>]. The function and gene products of <italic>phz</italic>C, <italic>phz</italic>E and <italic>phz</italic>D have been experimentally proven. These enzymes catalyze the conversion into 3-deoxy-<sc>d</sc>-<italic>arabino</italic>-heptulosonic acid 7-phosphate (DAHP), 2-amino-2-deoxyisochorismic acid (ADIC) and <italic>trans</italic>-2,3-dihydro-3-hydroxyanthranilic acid (DHHA) [<xref ref-type="bibr" rid="b17-marinedrugs-09-00772">17</xref>–<xref ref-type="bibr" rid="b20-marinedrugs-09-00772">20</xref>]. The phenazine core structure is synthesized subsequently by condensation of two molecules of 6-amino-5-oxocyclohex-2-ene-1-carboxylic acid [<xref ref-type="bibr" rid="b17-marinedrugs-09-00772">17</xref>]. Presumably, <italic>Phz</italic>F is responsible for the isomerization of DHHA [<xref ref-type="bibr" rid="b18-marinedrugs-09-00772">18</xref>]. By now, the function of the enzymes <italic>Phz</italic>A, <italic>Phz</italic>B and <italic>Phz</italic>G are almost enlightened [<xref ref-type="bibr" rid="b19-marinedrugs-09-00772">19</xref>] and their role in the condensation and rearrangement reactions to form PCA is demonstrated [<xref ref-type="bibr" rid="b17-marinedrugs-09-00772">17</xref>]. According to this information, the design of appropriate oligonucleotide probes and primers was possible. Mavrodi <italic>et al.</italic> (2010) [<xref ref-type="bibr" rid="b21-marinedrugs-09-00772">21</xref>] quite recently designed four different pairs of oligonucleotides on the basis of the <italic>phz</italic>F gene of the phenazine biosynthesis and investigated the diversity of phenazine producers mainly in soil-dwelling and plant-associated bacteria.</p>
<p>In particular marine bacteria have attracted our interest to search for promising natural products [<xref ref-type="bibr" rid="b1-marinedrugs-09-00772">1</xref>,<xref ref-type="bibr" rid="b22-marinedrugs-09-00772">22</xref>–<xref ref-type="bibr" rid="b26-marinedrugs-09-00772">26</xref>]. Therefore, we have investigated the possible application of a genetic approach for the detection of new marine isolates using <italic>phz</italic>E gene fragments as markers for the ability to produce bioactive phenazines. In contrast to Mavrodi <italic>et al.</italic> (2010) [<xref ref-type="bibr" rid="b21-marinedrugs-09-00772">21</xref>], we wanted to design a more universal primer system able to study a wide range of bacterial groups including actinomycetes and pseudomonades, in order to detect genes of phenazine production in unidentified new isolates without prior performance of a phylogenetic classification.</p></sec>
<sec sec-type="results|discussion">
<label>2.</label>
<title>Results and Discussion</title>
<p>The high diversity of microbes and their manifold biosynthetic capabilities offer a great potential for novel, bioactive secondary products. Genetic approaches such as the application of primer systems for NRPS, PKS or halogenases are efficient methods to select appropriate strains for further analyses [<xref ref-type="bibr" rid="b27-marinedrugs-09-00772">27</xref>,<xref ref-type="bibr" rid="b28-marinedrugs-09-00772">28</xref>]. The screening of bacteria for the presence of phenazine genes significantly adds to these selection filters. We report here on a rapid universal genetic system for the discovery of bacteria that are able to produce phenazines. The suitability of this PCR based screening approach for the identification of phenazine producing bacteria was demonstrated. A gene fragment indispensable for phenazine biosynthesis (<italic>phz</italic>E) served as a template for primer generation. As positive controls the type strain of <italic>S. cinnamonensis</italic>, and three subspecies of <italic>Pseudomonas chlororaphis</italic>, which are all well known producers of phenazines, were included in this study. For control strains several phenazine biosynthesis gene sequences were available at the NCBI (e.g., AM384985, HM594285, AF007801). Altogether 168 bacterial strains (including the four reference organisms) were examined for the presence of <italic>phz</italic>E. The PCR analysis was complemented by a chemical investigation in order to demonstrate the expression of the biosynthesis genes and to confirm the production of phenazines as proof of concept.</p>
<sec sec-type="methods">
<label>2.1.</label>
<title>Design of Oligonucleotides to Search for phzE Phenazine Gene Fragments</title>
<p>Former investigations were able to associate different steps of the phenazine biosynthetic pathway with the corresponding genes, e.g., <italic>phz</italic>C, <italic>phz</italic>D, <italic>phz</italic>E and <italic>phz</italic>F. The transformation from chorismate to 2-amino-2-deoxyisochorismic acid (ADIC) is necessary for the formation of the core structure of phenazines and is catalyzed by the enzyme <italic>Phz</italic>E. Thus, <italic>Phz</italic>E is a key enzyme in phenazine biosynthesis and the corresponding gene <italic>phz</italic>E is suitable for primer design. Sequences from the phenazine biosynthetic pathway for <italic>Alpha</italic>-, <italic>Beta</italic>- and <italic>Gammaproteobacteria, Actinomycetes</italic> and <italic>Firmicutes</italic> are available at the homepage of the National Centre for Biotechnology Information (NCBI) and known from literature [<xref ref-type="bibr" rid="b29-marinedrugs-09-00772">29</xref>,<xref ref-type="bibr" rid="b30-marinedrugs-09-00772">30</xref>]. To ensure the inclusion of only true phenazine sequences, oligonucleotide primers were constructed only from those genes known to be involved in the biosynthesis of corresponding chemical substances. Two conserved sites occurred within the alignment of <italic>phz</italic>E sequences (<xref ref-type="fig" rid="f2-marinedrugs-09-00772">Figure 2</xref>), which had a distance to each other to produce fragments of an appropriate length. The degenerated primers <italic>phz</italic>Ef (5′-GAA GGC GCC AAC TTC GTY ATC AA-3′) and <italic>phz</italic>Er (5′-GCC YTC GAT GAA GTA CTC GGT GTG-3′) were designed to amplify a highly conserved stretch of the <italic>phz</italic>E gene of approximately 450 bp. The comparison of the oligonucleotide sequences from designed <italic>phz</italic>Ef and <italic>phz</italic>Er primers with known phenazine genes verified this stretch as highly specific for <italic>phz</italic>E genes. Because the basic phenazine gene cluster including the <italic>phz</italic>E gene is highly conserved and derivatization of the basic phenazine structure are made at a later stage in the biosynthesis, the constructed <italic>phz</italic>E primers are expected to detect genes of a large variety of different phenazine structures and are appropriate to search for unknown bacteria producing novel phenazines.</p></sec>
<sec>
<label>2.2.</label>
<title>Screening for phzE Gene Fragments with the Constructed Primers</title>
<p>Genes belonging to the phenazine biosynthetic pathway were present in approximately 10% of the bacterial strains analyzed. PCR results of 13 (8%) out of 164 bacterial strains and four reference organisms were positive in regard to the presence of <italic>phz</italic>E gene fragments (<xref ref-type="fig" rid="f3-marinedrugs-09-00772">Figure 3</xref>, <xref ref-type="table" rid="t1-marinedrugs-09-00772">Tables 1</xref> and <xref ref-type="table" rid="t2-marinedrugs-09-00772">2</xref>). The investigated bacteria comprised different bacterial phyla, namely <italic>Actinobacteria</italic> (76), <italic>Bacteroidetes</italic> (2), <italic>Firmicutes</italic> (28) and <italic>Proteobacteria</italic> (62) (<xref ref-type="table" rid="t1-marinedrugs-09-00772">Table 1</xref>).</p>
<p>Corresponding gene fragments were detected in 11 strains of <italic>Actinobacteria</italic>, one strain of <italic>Firmicutes</italic> and two strains of the <italic>Alphaproteobacteria</italic>. All sequences were similar to known <italic>phz</italic>E gene sequences in a range from 65% similarity (<italic>phz</italic>E of strain LB151 to <italic>phz</italic>E of <italic>P. chlororaphis</italic>, AAF17499) to 95% similarity (<italic>phz</italic>E of strain AB108 to <italic>phz</italic>E of gene from <italic>S. cinnamonensis</italic>, CAL34110) (<xref ref-type="table" rid="t2-marinedrugs-09-00772">Table 2</xref>). Regarding the environmental isolates none of the strains within the <italic>Bacteroidetes, Beta</italic>- as well as <italic>Gammaproteobacteria</italic> could be shown to contain <italic>phz</italic>E in PCR amplification. This was unexpected, because among the 36 gammaproteobacterial isolates 18 <italic>Pseudomonas</italic> strains were examined and our PCR approach was performed with primer sequences largely based on sequences from <italic>Pseudomonas</italic> strains known as producers of phenazines [<xref ref-type="bibr" rid="b16-marinedrugs-09-00772">16</xref>,<xref ref-type="bibr" rid="b31-marinedrugs-09-00772">31</xref>,<xref ref-type="bibr" rid="b32-marinedrugs-09-00772">32</xref>]. The suitability of our primer set to detect phenazine genes in <italic>Pseudomonas</italic> species was further demonstrated by performing a database search that matched perfectly several phenazine genes, e.g., <italic>P. chlororaphis</italic> (L48339), <italic>Pseudomonas sp.</italic> M18 (FJ494909), <italic>P. aeruginosa</italic> (FM209186, CP000744, CP000438, AE004091, AF005404). Anyhow, a study based on <italic>phz</italic>F sequences exhibited a hit ratio of 100% including 51 <italic>Pseudomonas</italic> strains [<xref ref-type="bibr" rid="b21-marinedrugs-09-00772">21</xref>]. Therefore, all 18 pseudomonads from our study exhibiting negative results using <italic>phz</italic>E primers were subjected to a genetic approach with <italic>phz</italic>F primers. While the PCR-amplification of <italic>phz</italic>E and <italic>phz</italic>F gene fragments of the control type strains was positive (<xref ref-type="table" rid="t2-marinedrugs-09-00772">Table 2</xref>), amplification of the investigated isolates failed. As an additional control experiment, crude extracts of six <italic>Pseudomonas</italic> strains were analyzed by HPLC-UV/MS. Because of the distinctive properties of phenazine UV-absorption spectra the presence of phenazine metabolites was out of question. Additionally, for another study all natural products from two of the investigated <italic>Pseudomonas</italic> strains were isolated and chemically identified. No phenazines were detected. We conclude that the <italic>Pseudomonas</italic> strains analyzed in this study lack genes for phenazine production and are unable to produce phenazines. In agreement with this, the only known marine phenazine producing <italic>Pseudomonas</italic> species is <italic>P. aeruginosa</italic> [<xref ref-type="bibr" rid="b33-marinedrugs-09-00772">33</xref>–<xref ref-type="bibr" rid="b35-marinedrugs-09-00772">35</xref>], synthesizing almost always pyocyanin. In contrast, different marine streptomycetes are known for production of variable phenazine structures [<xref ref-type="bibr" rid="b9-marinedrugs-09-00772">9</xref>]. <italic>Streptomyces</italic> strains in this study are the most productive group as well. While <italic>Brevibacterium</italic>, <italic>Bacillus</italic> and <italic>Pelagibacter</italic> were known as marine phenazine producers [<xref ref-type="bibr" rid="b36-marinedrugs-09-00772">36</xref>–<xref ref-type="bibr" rid="b38-marinedrugs-09-00772">38</xref>], this is the first time that representatives of the genera <italic>Micromonospora</italic>, <italic>Kiloniella</italic> and <italic>Pseudovibrio</italic> were identified as marine phenazine producers as well.</p></sec>
<sec>
<label>2.3.</label>
<title>Detection of Phenazines in the phz<italic>E</italic> Positive Strains</title>
<p>To demonstrate the synthesis of phenazines in all <italic>phz</italic>E positive strains, cultures of these strains were extracted and analyzed by HPLC-UV/MS analyses. 14 out of 17 of these strains were able to produce one or more substances with molecular masses and UV-spectra similar to known phenazines (<xref ref-type="table" rid="t3-marinedrugs-09-00772">Table 3</xref>, <xref ref-type="fig" rid="f4-marinedrugs-09-00772">Figure 4a–c</xref>). In <italic>S. cinnamonensis</italic> DSM 1042<sup>T</sup> the production of endophenazines A–C (<xref ref-type="fig" rid="f5-marinedrugs-09-00772">Figure 5</xref>) and phenazine-1,6-dicarboxylic acid [<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>] could be demonstrated (<xref ref-type="fig" rid="f3-marinedrugs-09-00772">Figure 3a</xref>). The metabolite chlororaphin was discovered from <italic>Pseudomonas chlororaphis</italic> subsp. <italic>chlororaphis</italic> DSM 50083<sup>T</sup>. 2-hydroxy-phenazine (<xref ref-type="fig" rid="f5-marinedrugs-09-00772">Figure 5</xref>) and phenazine-1-carboxylic acid were produced by <italic>Pseudomonas chlororaphis</italic> subsp. <italic>aureofaciens</italic> DSM 6698<sup>T</sup> and <italic>Pseudomonas chlororaphis</italic> subsp. <italic>aurantiaca</italic> DSM 19603<sup>T</sup>. In addition, the presence of senacarcin A (strain <italic>Streptomyces</italic> sp. HB117), saphenyl ester D, aestivophoenin C and a derivative thereof (strains <italic>Streptomyces</italic> sp. HB122 and HB291) as well as phencomycin methyl ester and 1-carboxymethyl phenazine from strain <italic>Streptomyces</italic> sp. LB129 (<xref ref-type="fig" rid="f3-marinedrugs-09-00772">Figure 3b</xref>) were identified.</p>
<p>All environmental isolates producing phenazines (6%) were marine <italic>Streptomyces</italic> sp. or <italic>Micromonospora</italic> sp. strains. Most of these strains produced both known phenazines and phenazines which did not show any accordance to a database entry. In total, 22 known phenazines were identified. In the case of strain <italic>Streptomyces</italic> sp. HB202 (<xref ref-type="fig" rid="f4-marinedrugs-09-00772">Figure 4c</xref>), the production of streptophenazines A-H was verified using NMR spectroscopic analyses [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]. The large number of <italic>Streptomyces</italic> strains containing <italic>phz</italic>E genes is in good agreement with previous reports describing streptomycetes as a rich source for phenazines [<xref ref-type="bibr" rid="b9-marinedrugs-09-00772">9</xref>,<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>,<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>,<xref ref-type="bibr" rid="b40-marinedrugs-09-00772">40</xref>].</p>
<p>In nine of the culture extracts a total of 13 different substances showed typical phenazine like UV-absorption spectra, but gave no hit in the databases concerning UV and mass data. This indicates the presence of unidentified and possibly new natural phenazine products which warrant further investigation.</p>
<p>For some of the identified phenazines interesting biological activities were reported. Senacarcin A is known for its activity against Gram-positive bacteria and tumor cell lines [<xref ref-type="bibr" rid="b45-marinedrugs-09-00772">45</xref>] and aestivophoenin C has antioxidative activity and acts as a neuronal cell protecting substance [<xref ref-type="bibr" rid="b44-marinedrugs-09-00772">44</xref>]. Interesting bioactivities of phenazines are also known from the marine <italic>Streptomyces</italic> sp. strain HB202, which produced several streptophenazines with activity against Gram-positive bacteria [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>].</p>
<p>We expect that investigation of other so far unidentified phenazines from marine <italic>Actinobacteria</italic> is a remunerative challenge. Interestingly, phenazines were not detected in culture extracts of <italic>phz</italic>E positive strains of <italic>Alphaproteobacteria</italic> and <italic>Firmicutes</italic>. Though, all bacteria containing a <italic>phz</italic>E phenazine gene fragment have the capability to synthesize the phenazine core structure, proof of gene fragments from a biosynthetic pathway does not give evidence of the integrity of corresponding gene cluster. Additionally, the expression of a gene cluster under conditions used is not warranted. Therefore, it is most likely that the cultivation conditions used were not appropriate for the production of some of the phenazines and have to be modified for the selected strains by our genetic approach in further studies.</p></sec></sec>
<sec>
<label>3.</label>
<title>Experimental Section</title>
<sec>
<label>3.1.</label>
<title>Bacterial Strains and Their Phylogenetic Affiliation</title>
<p>166 bacterial strains used in this study were of diverse phylogenetic affiliation and were isolated from <italic>Halichondria panicea</italic> (HB strains) [<xref ref-type="bibr" rid="b46-marinedrugs-09-00772">46</xref>] and <italic>Saccharina latissima</italic> (synonym <italic>Laminaria saccharina</italic>) (LB strains) [<xref ref-type="bibr" rid="b47-marinedrugs-09-00772">47</xref>] collected at the Kiel Fjord, Germany, and also from different sponges collected from the Adriatic Sea near Rovinj, Croatia (AB strains). The strains belong to six different phylogenetic groups (<xref ref-type="table" rid="t1-marinedrugs-09-00772">Table 1</xref>). Additionally, type strains known to produce phenazines were used as positive controls: <italic>Streptomyces cinnamonensis</italic> DSM 1042<sup>T</sup>, <italic>Pseudomonas chlororaphis</italic> subsp. <italic>chlororaphis</italic> DSM 50083<sup>T</sup>, <italic>Pseudomonas chlororaphis</italic> subsp. <italic>aureofaciens</italic> DSM 6698<sup>T</sup>, and <italic>Pseudomonas chlororaphis</italic> subsp. <italic>aurantiaca</italic> DSM 19603<sup>T</sup>. For <italic>S. cinnamonensis</italic> DSM 1042<sup>T</sup> phenazine gene sequences and the production of different endophenazines and PCA (phenazine-1-carboxylic acid) have been demonstrated [<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>]. <italic>P. chlororaphis</italic> subsp. <italic>chlororaphis</italic> produced chlororaphin [<xref ref-type="bibr" rid="b48-marinedrugs-09-00772">48</xref>], <italic>P. chlororaphis</italic> subsp. <italic>aureofaciens</italic> and <italic>P. chlororaphis</italic> subsp. <italic>aurantiaca</italic> produces 2-hydroxy-phenazine [<xref ref-type="bibr" rid="b42-marinedrugs-09-00772">42</xref>] and phenazine-1-carboxylic acid [<xref ref-type="bibr" rid="b41-marinedrugs-09-00772">41</xref>], respectively.</p>
<p>For identification of the strains 16S rRNA gene sequence analyses were carried out according to Thiel <italic>et al.</italic> 2007 [<xref ref-type="bibr" rid="b49-marinedrugs-09-00772">49</xref>]. Comparison of the 16S rDNA sequences was performed using the EMBL nucleotide database available at the European Bioinformatics Institute homepage using the Basic Local Alignment Search Tool (nucleotide blast) [<xref ref-type="bibr" rid="b50-marinedrugs-09-00772">50</xref>] and the Ribosomal Database Project (RDP) database [<xref ref-type="bibr" rid="b51-marinedrugs-09-00772">51</xref>].</p></sec>
<sec sec-type="methods">
<label>3.2.</label>
<title>Design of Oligonucleotides for Molecular Detection of phzE Phenazine Gene Fragments</title>
<p>For the primer construction, amino acid sequences and nucleotide sequences of different <italic>phz</italic>E genes were retrieved from the European Bioinformatics Institute homepage and aligned using the program <italic>CLUSTAL_X</italic> [<xref ref-type="bibr" rid="b52-marinedrugs-09-00772">52</xref>]. Nucleotide sequences were deduced from amino acid sequences. The alignment was analyzed manually. The following <italic>phz</italic>E sequences were used for primer design: <italic>Streptomyces cinnamonensis</italic> (AM384985/CAL34110/68793…70757; putative 2-amino-2-desoxy-isochorismate synthase), <italic>Pseudomonas chlororaphis</italic> PCL1391 (AF195615/AAF17499/4873…6786; phenazine-1-carboxamide), <italic>Pseudomonas aeruginosa</italic> PAO1 (AF005404/AAC64488/3294…5177; pyocyanin), and <italic>Pseudomonas aeruginosa</italic> PAO1 (AE004091/AAG07601/4716660…4718543/AAG05292/2073555…2075438; phenazine biosynthesis protein PhzE). Primers (<xref ref-type="table" rid="t4-marinedrugs-09-00772">Table 4</xref>) were synthesized by MWG (Ebersbach, Germany). In order to check the specificity of the primers, the sequences of <italic>phz</italic>Ef and <italic>phz</italic>Er were compared with sequences from the EMBL database using the Basic Local Alignment Search Tool (<ext-link xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi" ext-link-type="uri">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>). This comparison revealed 100% identity of the primers with corresponding sites of phenazine biosynthesis genes. Since Ashenafi <italic>et al</italic>. (2008) [<xref ref-type="bibr" rid="b53-marinedrugs-09-00772">53</xref>] reported that the anthranilate synthase (SvTrpEG) of <italic>Streptomyces venezuelae</italic> has a high degree of amino acid sequence similarity to the phenazine biosynthetic enzyme PhzE, the corresponding nucleotide sequence (AF01267) was compared with the <italic>phz</italic>E primers using the bl2seq tool (<ext-link xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi" ext-link-type="uri">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>). No significant similarity was found indicating that false positive results are excluded.</p></sec>
<sec>
<label>3.3.</label>
<title>Amplification and Identification of the Phenazine Gene Fragments</title>
<p>The amplification reactions were carried out in a final volume of 25 μL. Taq DNA Polymerase (New England BioLabs, Ipswich, UK; MA, 5 U reaction<sup>−1</sup>) with the ThermoPol Buffer Kit (New England BioLabs, Ipswich, UK; MA, USA) was applied. Primers <italic>phz</italic>Ef and <italic>phz</italic>Er were deployed in a 10 μM concentration. 1 μL of a preparation containing each deoxynucleoside triphosphate at a concentration of 2.5 mM was used. 10 to 50 ng DNA of all strains used in this study was employed as template.</p>
<p>The amplification of the <italic>phz</italic>F gene sequence of the pseudomonads used in this study was performed using puReTaq Ready-To-Go polymerase chain reaction Beads (Amersham Biosciences, Uppsala, Sweden) with the primers Ps_up1 and Ps_low1 [<xref ref-type="bibr" rid="b21-marinedrugs-09-00772">21</xref>]. Cycler conditions for both PCR experiments were as follows: Initial denaturation: 94 °C for 120 s followed by 36 cycles of primer annealing at 54.7 °C <italic>(ph</italic>zE) and 57 °C (<italic>phz</italic>F), respectively, for 60 s; primer extension at 72 °C for 120 s and denaturation at 94 °C for 60 s. A final extension of 72 °C for 420 s was performed. All PCR reactions were conducted in a T1 thermocycler (Whatman Biometra<sup>®</sup>, Göttingen, Germany). Results of the amplifications were checked on a 1.5% agarose gel stained with ethidium bromide. DNA sequencing was done according to Wiese <italic>et al</italic>. [<xref ref-type="bibr" rid="b47-marinedrugs-09-00772">47</xref>]. The comparison of the <italic>phz</italic>E and <italic>phz</italic>F fragments, respectively, was done in the EMBL nucleotide database available at the European Bioinformatics Institute homepage using the Basic Local Alignment Search Tool (blastx) [<xref ref-type="bibr" rid="b50-marinedrugs-09-00772">50</xref>].</p></sec>
<sec>
<label>3.4.</label>
<title>Cultivation of phz<italic>E</italic> Strains</title>
<sec>
<label>3.4.1.</label>
<title>Cultivation of <italic>phz</italic>E Positive Strain</title>
<p>All strains with a positive result for phenazine gene fragments were cultivated for subsequent chemical analysis of their cell extracts. They were grown on GYM agar plate (4 g glucose, 4 g yeast extract, 4 g malt extract, 2 g CaCO<sub>3</sub>, 15 g agar, 1 L water, pH 7.2) or MB agar plate (37.4 g Difco marine broth, 15 g agar, 1 L water, pH 7.2) at 28 °C for 17 days as well as in 100 mL and 1000 mL GYM (4 g glucose, 4 g yeast extract, 4 g malt extract, 1 L water, pH 7.2) or MB medium (37.4 g Difco marine broth, 1 L water, pH 7.2) at 28 °C and 120 rpm for seven days. The three <italic>P. chlororaphis</italic> strains were cultivated in 1000 mL King B medium [<xref ref-type="bibr" rid="b56-marinedrugs-09-00772">56</xref>] at 28 °C and 120 rpm for 24 h.</p></sec>
<sec>
<label>3.4.2.</label>
<title>Cultivation of <italic>phz</italic>E Negative Strains</title>
<p>All strains with a negative result for phenazine gene fragments were cultivated for subsequent chemical analysis of their cell extracts. The precultures were grown on TSB medium agar plates (tryptic soy broth[Difco], 12 g/L; NaCl 20 g/L; agar 15 g/L) at 28 °C for 1 day. A 1 cm<sup>2</sup> piece of the agar plate was used for inoculation of the main culture. Main cultures were grown in 100 mL TSB medium (with four baffles) and KingB medium [<xref ref-type="bibr" rid="b56-marinedrugs-09-00772">56</xref>] at 28 °C and 120 rpm for one, three and six days.</p></sec></sec>
<sec>
<label>3.5.</label>
<title>Culture Extracts of phzE Positive and Negative Strains</title>
<p>For 1 L cultures the supernatants were separated from the cell mass pellets by centrifugation at 4.700 × g for 20 min and extracted separately. Cells were homogenized by addition of 150 mL 96% EtOH and using Ultra-Turrax (IKA, Staufen, Germany) at 13,000 rpm for 30 s. The extracts were dried <italic>in vacuo</italic> and redissolved in MeOH for further analyses. Supernatants and the other cultures were extracted with EtOAc by homogenization with the help of Ultra-Turrax at 16,000 rpm for 30 s, also dried <italic>in vacuo</italic> and redissolved in MeOH for further analyses.</p></sec>
<sec sec-type="methods">
<label>3.6.</label>
<title>Chemical Analysis of phzE Positive and Negative Strains</title>
<p>Reversed phase HPLC experiments were performed using a C<sub>18</sub> column (Phenomenex Onyx Monolithic C18, 100 × 3.00 mm) applying an H<sub>2</sub>O (A)/MeCN (B) gradient with 0.1% HCOOH added to both solvents (gradient 0 min 5% B, 4 min 60% B, 6 min 100% B; flow 2 mL/min) on a VWR Hitachi Elite LaChrom system coupled to an ESI-ion trap detector (Esquire 4000, Bruker Daltonics). Dereplication of substances was realized by comparison of MS and UV data obtained by HPLC-UV/MS analyses used data from the Antibase [<xref ref-type="bibr" rid="b57-marinedrugs-09-00772">57</xref>] and the Chapman &amp; Hall/CRC Dictionary of Natural Products databases [<xref ref-type="bibr" rid="b58-marinedrugs-09-00772">58</xref>]. For endophenazines A and B, 2-hydroxy-phenazine and phenazine-1-carboxylic acid structure was confirmed by <sup>1</sup>H NMR analysis.</p></sec>
<sec>
<label>3.7.</label>
<title>Nucleotide Sequence Accession Numbers</title>
<p>The nucleotide sequence data reported in the present study were deposited in the GenBank nucleotide sequence database under the accession numbers HM460698 (AB049), HM460699 (AB108), AJ849545 (YIM 90018), AM231308 (YIM 36723), GQ863906 (HB117), GQ863907 (HB122), GQ863918 (HB202), GQ863921 (HB253), GQ863922 (HB254), GQ863926 (HB291), AM749667 (LB066), AM913982 (LB114), AM913952 (LB129), AM913970 (LB150) and AM913971 (LB151) for 16S rRNA and HM460700-HM460715 for <italic>phz</italic>E gene fragments.</p></sec></sec>
<sec sec-type="conclusions">
<label>4.</label>
<title>Conclusions</title>
<p>In conclusion, the application of the <italic>phz</italic>E primer system is a useful tool to indicate the presence of the phenazine biosynthetic pathway in various groups of bacteria. The proof of concept was shown for well known producers of phenazines, but also for marine <italic>Streptomyces</italic> sp. strain. This approach is particularly relevant, because many marine <italic>Actinobacteria</italic> turned out to be active phenazine producers and <italic>Streptomyces</italic> strains are known to synthesize phenazines with anticancer and/or anti-infective activities [<xref ref-type="bibr" rid="b59-marinedrugs-09-00772">59</xref>]. The method used in this study offers a promising method to test the ability of producing phenazines in new isolates of all kinds of bacteria including marine <italic>Actinobacteria.</italic></p></sec></body>
<back>
<ack>
<p>The authors gratefully thank B. Ohlendorf and N. Jansen for the NMR-analyses, A. Labes and I. Kajahn for fruitful discussions and K. Schumann for help with the cultivation experiments This study was supported by the Ministerium für Wissenschaft, Wirtschaft und Verkehr in the frame of the program “Zukunft Wirtschaft”, which is co-financed by the European Union (EFRE).</p></ack>
<fn-group><fn>
<p><italic>Samples Availability</italic>: Available from the authors.</p></fn></fn-group>
<ref-list>
<title>References</title>
<ref id="b1-marinedrugs-09-00772"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blunt</surname><given-names>JW</given-names></name><name><surname>Copp</surname><given-names>BR</given-names></name><name><surname>Munro</surname><given-names>MHG</given-names></name><name><surname>Northcote</surname><given-names>PT</given-names></name><name><surname>Prinsep</surname><given-names>MR</given-names></name></person-group><article-title>Marine natural products</article-title><source>Nat Prod Rep</source><year>2011</year><volume>28</volume><fpage>196</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1039/c005001f</pub-id><pub-id pub-id-type="pmid">21152619</pub-id></citation></ref>
<ref id="b2-marinedrugs-09-00772"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group><article-title>Natural products as sources of new drugs over the last 25 years</article-title><source>J Nat Prod</source><year>2007</year><volume>70</volume><fpage>461</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1021/np068054v</pub-id><pub-id pub-id-type="pmid">17309302</pub-id></citation></ref>
<ref id="b3-marinedrugs-09-00772"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>MS</given-names></name></person-group><article-title>Natural products to drugs: Natural product-derived compounds in clinical trials</article-title><source>Nat Prod Rep</source><year>2008</year><volume>25</volume><fpage>475</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1039/b514294f</pub-id><pub-id pub-id-type="pmid">18497896</pub-id></citation></ref>
<ref id="b4-marinedrugs-09-00772"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donadio</surname><given-names>S</given-names></name><name><surname>Monciardini</surname><given-names>P</given-names></name><name><surname>Sosio</surname><given-names>M</given-names></name></person-group><article-title>Polyketide synthases and nonribosomal peptide synthetases: The emerging view from bacterial genomics</article-title><source>Nat Prod Rep</source><year>2007</year><volume>24</volume><fpage>1073</fpage><lpage>1109</lpage><pub-id pub-id-type="doi">10.1039/b514050c</pub-id><pub-id pub-id-type="pmid">17898898</pub-id></citation></ref>
<ref id="b5-marinedrugs-09-00772"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Willey</surname><given-names>JM</given-names></name><name><surname>van der Donk</surname><given-names>WA</given-names></name></person-group><article-title>Lantibiotics: Peptides of diverse structure and function</article-title><source>Annu Rev Microbiol</source><year>2007</year><volume>61</volume><fpage>477</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.61.080706.093501</pub-id><pub-id pub-id-type="pmid">17506681</pub-id></citation></ref>
<ref id="b6-marinedrugs-09-00772"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arbiser</surname><given-names>JL</given-names></name><name><surname>Moschella</surname><given-names>SL</given-names></name></person-group><article-title>Clofazimine: A review of its medical uses and mechanisms of action</article-title><source>J Am Acad Dermatol</source><year>1995</year><volume>32</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/0190-9622(95)90134-5</pub-id><pub-id pub-id-type="pmid">7829710</pub-id></citation></ref>
<ref id="b7-marinedrugs-09-00772"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>M</given-names></name><name><surname>Mavrodi</surname><given-names>DV</given-names></name><name><surname>Thomashow</surname><given-names>LS</given-names></name><name><surname>Floss</surname><given-names>HG</given-names></name></person-group><article-title>Phenazine biosynthesis in <italic>Pseudomonas fluorescens</italic>: Branchpoint from the primary shikimate biosynthetic pathway and role of phenazine-1,6-dicarboxylic acid</article-title><source>J Am Chem Soc</source><year>2001</year><volume>123</volume><fpage>9459</fpage><lpage>9460</lpage><pub-id pub-id-type="doi">10.1021/ja011243+</pub-id><pub-id pub-id-type="pmid">11562236</pub-id></citation></ref>
<ref id="b8-marinedrugs-09-00772"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pierson</surname><given-names>LS</given-names><suffix>III</suffix></name><name><surname>Gaffney</surname><given-names>T</given-names></name><name><surname>Lam</surname><given-names>S</given-names></name><name><surname>Gong</surname><given-names>F</given-names></name></person-group><article-title>Molecular analysis of genes encoding phenazine biosynthesis in the biological control bacterium <italic>Pseudomonas aureofaciens</italic> 30–84</article-title><source>FEMS Microbiol Lett</source><year>1995</year><volume>134</volume><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">8586283</pub-id></citation></ref>
<ref id="b9-marinedrugs-09-00772"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pusecker</surname><given-names>K</given-names></name><name><surname>Laatsch</surname><given-names>H</given-names></name><name><surname>Helmke</surname><given-names>E</given-names></name><name><surname>Weyland</surname><given-names>H</given-names></name></person-group><article-title>Dihydrophencomycin methyl ester, a new phenazine derivative from a marine Streptomycete</article-title><source>J Antibiot</source><year>1997</year><volume>50</volume><fpage>479</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.50.479</pub-id><pub-id pub-id-type="pmid">9268003</pub-id></citation></ref>
<ref id="b10-marinedrugs-09-00772"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Niekerk</surname><given-names>S</given-names></name><name><surname>Huygens</surname><given-names>F</given-names></name><name><surname>van Rensburg</surname><given-names>CEJ</given-names></name></person-group><article-title>A time-kill study to evaluate the <italic>in vitro</italic> activity of clofazimine in combination with cefotaxime against a penicillin- and cefotaxime-resistant strain of <italic>Streptococcus pneumoniae</italic></article-title><source>J Antimicrob Chemother</source><year>1997</year><volume>40</volume><fpage>602</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1093/jac/40.4.602</pub-id><pub-id pub-id-type="pmid">9372436</pub-id></citation></ref>
<ref id="b11-marinedrugs-09-00772"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Rensburg</surname><given-names>CEJ</given-names></name><name><surname>Joone</surname><given-names>GK</given-names></name><name><surname>O’Sullivan</surname><given-names>JF</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name></person-group><article-title>Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids</article-title><source>Antimicrob Agents Chemother</source><year>1992</year><volume>36</volume><fpage>2729</fpage><lpage>2735</lpage><pub-id pub-id-type="doi">10.1128/AAC.36.12.2729</pub-id><pub-id pub-id-type="pmid">1482140</pub-id></citation></ref>
<ref id="b12-marinedrugs-09-00772"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mavrodi</surname><given-names>DV</given-names></name><name><surname>Blankenfeldt</surname><given-names>W</given-names></name><name><surname>Thomashow</surname><given-names>LS</given-names></name></person-group><article-title>Phenazine compounds in fluorescent <italic>Pseudomonas</italic> spp. biosynthesis and regulation</article-title><source>Annu Rev Phytopathol</source><year>2006</year><volume>44</volume><fpage>417</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1146/annurev.phyto.44.013106.145710</pub-id><pub-id pub-id-type="pmid">16719720</pub-id></citation></ref>
<ref id="b13-marinedrugs-09-00772"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>VM</given-names></name><name><surname>O’Sullivan</surname><given-names>JF</given-names></name><name><surname>Gangadharam</surname><given-names>PR</given-names></name></person-group><article-title>Antimycobacterial activities of riminophenazines</article-title><source>J Antimicrob Chemother</source><year>1999</year><volume>43</volume><fpage>615</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1093/jac/43.5.615</pub-id><pub-id pub-id-type="pmid">10382882</pub-id></citation></ref>
<ref id="b14-marinedrugs-09-00772"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spicer</surname><given-names>JA</given-names></name><name><surname>Gamage</surname><given-names>SA</given-names></name><name><surname>Rewcastle</surname><given-names>GW</given-names></name><name><surname>Finlay</surname><given-names>GJ</given-names></name><name><surname>Bridewell</surname><given-names>DJ</given-names></name><name><surname>Baguley</surname><given-names>BC</given-names></name><name><surname>Denny</surname><given-names>WA</given-names></name></person-group><article-title>Bis(phenazine-1-carboxamides): Structure-activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugs</article-title><source>J Med Chem</source><year>2000</year><volume>43</volume><fpage>1350</fpage><lpage>1358</lpage><pub-id pub-id-type="doi">10.1021/jm990423f</pub-id><pub-id pub-id-type="pmid">10753472</pub-id></citation></ref>
<ref id="b15-marinedrugs-09-00772"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haagen</surname><given-names>Y</given-names></name><name><surname>Glück</surname><given-names>K</given-names></name><name><surname>Fay</surname><given-names>K</given-names></name><name><surname>Kammerer</surname><given-names>B</given-names></name><name><surname>Gust</surname><given-names>B</given-names></name><name><surname>Heide</surname><given-names>L</given-names></name></person-group><article-title>A gene cluster for prenylated naphthoquinone and prenylated phenazine biosynthesis in <italic>Streptomyces cinnamonensis</italic> DSM 1042</article-title><source>Chembiochem</source><year>2006</year><volume>7</volume><fpage>2016</fpage><lpage>2027</lpage><pub-id pub-id-type="doi">10.1002/cbic.200600338</pub-id><pub-id pub-id-type="pmid">17103476</pub-id></citation></ref>
<ref id="b16-marinedrugs-09-00772"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mavrodi</surname><given-names>DV</given-names></name><name><surname>Ksenzenko</surname><given-names>VN</given-names></name><name><surname>Bonsall</surname><given-names>RF</given-names></name><name><surname>Cook</surname><given-names>RJ</given-names></name><name><surname>Boronin</surname><given-names>AM</given-names></name><name><surname>Thomashow</surname><given-names>LS</given-names></name></person-group><article-title>A seven-gene locus for synthesis of phenazine-1-carboxylic acid by <italic>Pseudomonas fluorescens</italic> 2-79</article-title><source>J Bacteriol</source><year>1998</year><volume>180</volume><fpage>2541</fpage><lpage>2548</lpage><pub-id pub-id-type="pmid">9573209</pub-id></citation></ref>
<ref id="b17-marinedrugs-09-00772"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mentel</surname><given-names>M</given-names></name><name><surname>Ahuja</surname><given-names>EG</given-names></name><name><surname>Mavrodi</surname><given-names>DV</given-names></name><name><surname>Breinbauer</surname><given-names>R</given-names></name><name><surname>Thomashow</surname><given-names>LS</given-names></name><name><surname>Blankenfeldt</surname><given-names>W</given-names></name></person-group><article-title>Of two make one: The biosynthesis of phenazines</article-title><source>Chembiochem</source><year>2009</year><volume>10</volume><fpage>2295</fpage><lpage>2304</lpage><pub-id pub-id-type="doi">10.1002/cbic.200900323</pub-id><pub-id pub-id-type="pmid">19658148</pub-id></citation></ref>
<ref id="b18-marinedrugs-09-00772"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>M</given-names></name><name><surname>Mavrodi</surname><given-names>DV</given-names></name><name><surname>Thomashow</surname><given-names>LS</given-names></name><name><surname>Floss</surname><given-names>HG</given-names></name></person-group><article-title>Phenazine biosynthesis in <italic>Pseudomonas fluorescens</italic>: Branchpoint from the primary shikimate biosynthetic pathway and role of phenazine-1,6-dicarboxylic acid</article-title><source>J Am Chem Soc</source><year>2001</year><volume>123</volume><fpage>9459</fpage><lpage>9460</lpage><pub-id pub-id-type="doi">10.1021/ja011243+</pub-id><pub-id pub-id-type="pmid">11562236</pub-id></citation></ref>
<ref id="b19-marinedrugs-09-00772"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pierson</surname><given-names>LS</given-names><suffix>III</suffix></name><name><surname>Pierson</surname><given-names>EA</given-names></name></person-group><article-title>Metabolism and function of phenazines in bacteria: Impacts on the behavior of bacteria in the environment and biotechnological processes</article-title><source>Appl Microbiol Biotech</source><year>2010</year><volume>86</volume><fpage>1659</fpage><lpage>1670</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2509-3</pub-id></citation></ref>
<ref id="b20-marinedrugs-09-00772"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calhoun</surname><given-names>DH</given-names></name><name><surname>Carson</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>RA</given-names></name></person-group><article-title>The branch point metabolite for pyocyanine biosynthesis in <italic>Pseudomonas aeruginosa</italic></article-title><source>J Gen Microbiol</source><year>1972</year><volume>72</volume><fpage>581</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">4629136</pub-id></citation></ref>
<ref id="b21-marinedrugs-09-00772"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mavrodi</surname><given-names>DV</given-names></name><name><surname>Peever</surname><given-names>TL</given-names></name><name><surname>Mavrodi</surname><given-names>OV</given-names></name><name><surname>Parejko</surname><given-names>JA</given-names></name><name><surname>Raaijmakers</surname><given-names>JM</given-names></name><name><surname>lemanceau</surname><given-names>P</given-names></name><name><surname>Mazurier</surname><given-names>S</given-names></name><name><surname>Heide</surname><given-names>L</given-names></name><name><surname>Blankenfeldt</surname><given-names>W</given-names></name><name><surname>Weller</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Diversity and evolution of the phenazine biosynthesis pathway</article-title><source>Appl Environ Microbiol</source><year>2010</year><volume>76</volume><fpage>866</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1128/AEM.02009-09</pub-id><pub-id pub-id-type="pmid">20008172</pub-id></citation></ref>
<ref id="b22-marinedrugs-09-00772"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fiedler</surname><given-names>HP</given-names></name><name><surname>Bruntner</surname><given-names>C</given-names></name><name><surname>Bull</surname><given-names>AT</given-names></name><name><surname>Ward</surname><given-names>AC</given-names></name><name><surname>Goodfellow</surname><given-names>M</given-names></name><name><surname>Potterat</surname><given-names>O</given-names></name><name><surname>Puder</surname><given-names>C</given-names></name><name><surname>Mihm</surname><given-names>G</given-names></name></person-group><article-title>Marine actinomycetes as a source of novel secondary metabolites</article-title><source>Anton Leeuwenhoek</source><year>2005</year><volume>87</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s10482-004-6538-8</pub-id></citation></ref>
<ref id="b23-marinedrugs-09-00772"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>PR</given-names></name><name><surname>Mincer</surname><given-names>TJ</given-names></name><name><surname>Williams</surname><given-names>PG</given-names></name><name><surname>Fenical</surname><given-names>W</given-names></name></person-group><article-title>Marine actinomycete diversity and natural product discovery</article-title><source>Anton Leeuwenhoek</source><year>2005</year><volume>87</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1007/s10482-004-6540-1</pub-id></citation></ref>
<ref id="b24-marinedrugs-09-00772"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salomon</surname><given-names>CE</given-names></name><name><surname>Magarvey</surname><given-names>NA</given-names></name><name><surname>Sherman</surname><given-names>DH</given-names></name></person-group><article-title>Merging the potential of microbial genetics with biological and chemical diversity: An even brighter future for marine natural product drug discovery</article-title><source>Nat Prod Rep</source><year>2004</year><volume>21</volume><fpage>105</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1039/b301384g</pub-id><pub-id pub-id-type="pmid">15039838</pub-id></citation></ref>
<ref id="b25-marinedrugs-09-00772"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>PG</given-names></name></person-group><article-title>Panning for chemical gold: Marine bacteria as a source of new therapeutics</article-title><source>Trends Biotech</source><year>2009</year><volume>27</volume><fpage>45</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.tibtech.2008.10.005</pub-id></citation></ref>
<ref id="b26-marinedrugs-09-00772"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gulder</surname><given-names>TAM</given-names></name><name><surname>Moore</surname><given-names>BS</given-names></name></person-group><article-title>Chasing the treasures of the sea—Bacterial marine natural products</article-title><source>Curr Opin Microbiol</source><year>2009</year><volume>12</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2009.05.002</pub-id><pub-id pub-id-type="pmid">19481972</pub-id></citation></ref>
<ref id="b27-marinedrugs-09-00772"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metsä-Ketelä</surname><given-names>M</given-names></name><name><surname>Salo</surname><given-names>V</given-names></name><name><surname>Halo</surname><given-names>L</given-names></name><name><surname>Hautala</surname><given-names>A</given-names></name><name><surname>Hakala</surname><given-names>J</given-names></name><name><surname>Mäntsälä</surname><given-names>P</given-names></name><name><surname>Ylihonko</surname><given-names>K</given-names></name></person-group><article-title>An efficient approach for screening minimal PKS genes from <italic>Streptomyces</italic></article-title><source>FEMS Microbiol Lett</source><year>1999</year><volume>180</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10547437</pub-id></citation></ref>
<ref id="b28-marinedrugs-09-00772"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piel</surname><given-names>J</given-names></name></person-group><article-title>A polyketide synthase-peptide synthetases gene cluster from an uncultured bacterial symbiont of <italic>Paederus</italic> beetles</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>14002</fpage><lpage>14007</lpage><pub-id pub-id-type="doi">10.1073/pnas.222481399</pub-id><pub-id pub-id-type="pmid">12381784</pub-id></citation></ref>
<ref id="b29-marinedrugs-09-00772"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laursen</surname><given-names>JB</given-names></name><name><surname>de Visser</surname><given-names>PC</given-names></name><name><surname>Nielsen</surname><given-names>HK</given-names></name><name><surname>Jensen</surname><given-names>KJ</given-names></name><name><surname>Nielsen</surname><given-names>J</given-names></name></person-group><article-title>Solid-phase synthesis of new saphenamycin analogues with antimicrobial activity</article-title><source>Bioorg Med Chem Lett</source><year>2002</year><volume>12</volume><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(01)00692-8</pub-id><pub-id pub-id-type="pmid">11755347</pub-id></citation></ref>
<ref id="b30-marinedrugs-09-00772"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Price-Whelan</surname><given-names>A</given-names></name><name><surname>Dietrich</surname><given-names>LE</given-names></name><name><surname>Newman</surname><given-names>DK</given-names></name></person-group><article-title>Rethinking ‘secondary’ metabolism: Physiological roles for phenazine antibiotics</article-title><source>Nat Chem Biol</source><year>2006</year><volume>2</volume><fpage>71</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1038/nchembio764</pub-id><pub-id pub-id-type="pmid">16421586</pub-id></citation></ref>
<ref id="b31-marinedrugs-09-00772"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomashow</surname><given-names>LS</given-names></name><name><surname>Weller</surname><given-names>DM</given-names></name><name><surname>Bonsall</surname><given-names>RF</given-names></name><name><surname>Pierson</surname><given-names>LS</given-names></name></person-group><article-title>Production of the antibiotic phenazine-1-carboxylic acid by fluorescent <italic>Pseudomonas</italic> species in the rhizosphere of wheat</article-title><source>Appl Environ Microbiol</source><year>1990</year><volume>56</volume><fpage>908</fpage><lpage>912</lpage><pub-id pub-id-type="pmid">16348176</pub-id></citation></ref>
<ref id="b32-marinedrugs-09-00772"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>R</given-names></name><name><surname>Sykes</surname><given-names>DA</given-names></name><name><surname>Watson</surname><given-names>D</given-names></name><name><surname>Rutman</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>GW</given-names></name><name><surname>Cole</surname><given-names>PJ</given-names></name></person-group><article-title>Measurement of <italic>Pseudomonas aeruginosa</italic> phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium</article-title><source>Infect Immun</source><year>1988</year><volume>56</volume><fpage>2515</fpage><lpage>2517</lpage><pub-id pub-id-type="pmid">3137173</pub-id></citation></ref>
<ref id="b33-marinedrugs-09-00772"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Angell</surname><given-names>S</given-names></name><name><surname>Bench</surname><given-names>BJ</given-names></name><name><surname>Williams</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>CMH</given-names></name></person-group><article-title>Pyocyanin isolated from a marine microbial population: Synergistic production between two distinct bacterial species and mode of action</article-title><source>Chem Biol</source><year>2006</year><volume>13</volume><fpage>1349</fpage><lpage>1359</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2006.10.012</pub-id><pub-id pub-id-type="pmid">17185230</pub-id></citation></ref>
<ref id="b34-marinedrugs-09-00772"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Isnansetyo</surname><given-names>A</given-names></name><name><surname>Kamei</surname><given-names>Y</given-names></name></person-group><article-title>Bioactive substances produced by marine isolates of <italic>Pseudomonas</italic></article-title><source>J Ind Microbiol Biotech</source><year>2009</year><volume>36</volume><fpage>1239</fpage><lpage>1248</lpage><pub-id pub-id-type="doi">10.1007/s10295-009-0611-2</pub-id></citation></ref>
<ref id="b35-marinedrugs-09-00772"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jayatilake</surname><given-names>GS</given-names></name><name><surname>Thornton</surname><given-names>MP</given-names></name><name><surname>Leonard</surname><given-names>AC</given-names></name><name><surname>Grimwade</surname><given-names>JE</given-names></name><name><surname>Baker</surname><given-names>BJ</given-names></name></person-group><article-title>Metabolites from an Antarctic sponge-associated bacterium, <italic>Pseudomonas aeruginosa</italic></article-title><source>J Nat Prod</source><year>1996</year><volume>59</volume><fpage>293</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1021/np960095b</pub-id><pub-id pub-id-type="pmid">8882433</pub-id></citation></ref>
<ref id="b36-marinedrugs-09-00772"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname><given-names>N</given-names></name><name><surname>Nishijima</surname><given-names>M</given-names></name><name><surname>Takadera</surname><given-names>T</given-names></name><name><surname>Adachi</surname><given-names>K</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Sano</surname><given-names>H</given-names></name></person-group><article-title>New anticancer antibiotics pelagiomicins, produced by a new marine bacterium <italic>Pelagiobacter variabilis</italic></article-title><source>J Antibiot</source><year>1997</year><volume>50</volume><fpage>8</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.50.8</pub-id><pub-id pub-id-type="pmid">9066759</pub-id></citation></ref>
<ref id="b37-marinedrugs-09-00772"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>EJ</given-names></name><name><surname>Kwon</surname><given-names>HC</given-names></name><name><surname>Ham</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>HO</given-names></name></person-group><article-title>6-Hydroxymethyl-1-phenazine-carboxamide and 1,6-phenazinedimethanol from a marine bacterium, <italic>Brevibacterium</italic> sp. KMD 003, associated with marine purple vase sponge</article-title><source>J Antibiot</source><year>2009</year><volume>62</volume><fpage>621</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1038/ja.2009.92</pub-id><pub-id pub-id-type="pmid">19798118</pub-id></citation></ref>
<ref id="b38-marinedrugs-09-00772"><label>38.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Gu</surname><given-names>QQ</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name></person-group><article-title>A new cytotoxic phenazine derivative from a deep sea bacterium <italic>Bacillus</italic> sp</article-title><source>Arch Pharm Res</source><year>2007</year><volume>30</volume><fpage>552</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1007/BF02977647</pub-id><pub-id pub-id-type="pmid">17615672</pub-id></citation></ref>
<ref id="b39-marinedrugs-09-00772"><label>39.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mitova</surname><given-names>MI</given-names></name><name><surname>Lang</surname><given-names>G</given-names></name><name><surname>Wiese</surname><given-names>J</given-names></name><name><surname>Imhoff</surname><given-names>JF</given-names></name></person-group><article-title>Subinhibitory concentrations of antibiotics induce phenazine production in a marine <italic>Streptomyces</italic> sp</article-title><source>J Nat Prod</source><year>2008</year><volume>71</volume><fpage>824</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1021/np800032a</pub-id><pub-id pub-id-type="pmid">18396903</pub-id></citation></ref>
<ref id="b40-marinedrugs-09-00772"><label>40.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JM</given-names></name><name><surname>Messenger</surname><given-names>AJ</given-names></name></person-group><article-title>Occurrence, biochemistry and physiology of phenazine pigment production</article-title><source>Adv Microb Physiol</source><year>1986</year><volume>27</volume><fpage>211</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">3532716</pub-id></citation></ref>
<ref id="b41-marinedrugs-09-00772"><label>41.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brisbane</surname><given-names>PG</given-names></name><name><surname>Janik</surname><given-names>LJ</given-names></name><name><surname>Tate</surname><given-names>ME</given-names></name><name><surname>Warren</surname><given-names>RF</given-names></name></person-group><article-title>Revised structure for the phenazine antibiotic from <italic>Pseudomonas fluorescens</italic> 2–79 (NRRL B-15132)</article-title><source>Antimicrob Agents Chemother</source><year>1987</year><volume>31</volume><fpage>1967</fpage><lpage>1971</lpage><pub-id pub-id-type="doi">10.1128/AAC.31.12.1967</pub-id><pub-id pub-id-type="pmid">3125789</pub-id></citation></ref>
<ref id="b42-marinedrugs-09-00772"><label>42.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levitch</surname><given-names>ME</given-names></name><name><surname>Rietz</surname><given-names>P</given-names></name></person-group><article-title>The isolation and characterization of 2-hydroxyphenazine from <italic>Pseudomonas aureofaciens</italic></article-title><source>Biochemistry</source><year>1966</year><volume>5</volume><fpage>689</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1021/bi00866a040</pub-id><pub-id pub-id-type="pmid">5940951</pub-id></citation></ref>
<ref id="b43-marinedrugs-09-00772"><label>43.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanner</surname><given-names>D</given-names></name><name><surname>Gerber</surname><given-names>NN</given-names></name><name><surname>Bartha</surname><given-names>R</given-names></name></person-group><article-title>Pattern of phenazine pigment production by a strain of <italic>Pseudomonas aeruginosa</italic></article-title><source>J Bacteriol</source><year>1978</year><volume>134</volume><fpage>690</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">96094</pub-id></citation></ref>
<ref id="b44-marinedrugs-09-00772"><label>44.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kunigami</surname><given-names>T</given-names></name><name><surname>Shin-Ya</surname><given-names>K</given-names></name><name><surname>Furihata</surname><given-names>K</given-names></name><name><surname>Furihata</surname><given-names>K</given-names></name><name><surname>Hayakawa</surname><given-names>Y</given-names></name><name><surname>Seto</surname><given-names>H</given-names></name></person-group><article-title>A novel neuronal cell protecting substance, aestivophoenin C, produced by <italic>Streptomyces purpeofuscus</italic></article-title><source>J Antibiot</source><year>1998</year><volume>51</volume><fpage>880</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.51.880</pub-id><pub-id pub-id-type="pmid">9820239</pub-id></citation></ref>
<ref id="b45-marinedrugs-09-00772"><label>45.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Shirahata</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>S</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Morimoto</surname><given-names>M</given-names></name><name><surname>Tomita</surname><given-names>F</given-names></name></person-group><article-title>Senacarcin A, a new antitumor antibiotic produced <italic>by Streptomyces endus</italic> subsp <italic>aureus</italic></article-title><source>J Antibiot</source><year>1982</year><volume>35</volume><fpage>760</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.35.760</pub-id><pub-id pub-id-type="pmid">7118728</pub-id></citation></ref>
<ref id="b46-marinedrugs-09-00772"><label>46.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneemann</surname><given-names>I</given-names></name><name><surname>Nagel</surname><given-names>K</given-names></name><name><surname>Kajahn</surname><given-names>I</given-names></name><name><surname>Labes</surname><given-names>A</given-names></name><name><surname>Wiese</surname><given-names>J</given-names></name><name><surname>Imhoff</surname><given-names>JF</given-names></name></person-group><article-title>Comprehensive investigations of marine <italic>Actinobacteria</italic> associated with the sponge <italic>Halichondria panicea</italic></article-title><source>Appl Environ Microbiol</source><year>2010</year><volume>76</volume><fpage>3702</fpage><lpage>3714</lpage><pub-id pub-id-type="doi">10.1128/AEM.00780-10</pub-id><pub-id pub-id-type="pmid">20382810</pub-id></citation></ref>
<ref id="b47-marinedrugs-09-00772"><label>47.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiese</surname><given-names>J</given-names></name><name><surname>Thiel</surname><given-names>V</given-names></name><name><surname>Nagel</surname><given-names>K</given-names></name><name><surname>Staufenberger</surname><given-names>T</given-names></name><name><surname>Imhoff</surname><given-names>JF</given-names></name></person-group><article-title>Diversity of antibiotic-active bacteria associated with the brown alga <italic>Laminaria saccharina</italic> from the Baltic Sea</article-title><source>Mar Biotech</source><year>2009</year><volume>11</volume><fpage>287</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1007/s10126-008-9143-4</pub-id></citation></ref>
<ref id="b48-marinedrugs-09-00772"><label>48.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peix</surname><given-names>A</given-names></name><name><surname>Valverde</surname><given-names>A</given-names></name><name><surname>Rivas</surname><given-names>R</given-names></name><name><surname>Igual</surname><given-names>JM</given-names></name><name><surname>Ramírez-Bahena</surname><given-names>MH</given-names></name><name><surname>Mateos</surname><given-names>PF</given-names></name><name><surname>Santa-Regina</surname><given-names>I</given-names></name><name><surname>Rodríguez-Barrueco</surname><given-names>C</given-names></name><name><surname>Martínez-Molina</surname><given-names>E</given-names></name><name><surname>Velázquez</surname><given-names>E</given-names></name></person-group><article-title>Reclassification of <italic>Pseudomonas aurantiaca</italic> as a synonym of <italic>Pseudomonas chlororaphis</italic> and proposal of three subspecies, <italic>P. chlororaphis</italic> subsp. <italic>chlororaphis</italic> subsp. nov., <italic>P. chlororaphis</italic> subsp. <italic>aureofaciens</italic> subsp. nov., comb. nov. and <italic>P. chlororaphis</italic> subsp. <italic>aurantiaca</italic> subsp. nov., comb. nov</article-title><source>Int J Syst Evol Microbiol</source><year>2007</year><volume>57</volume><fpage>1286</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1099/ijs.0.64621-0</pub-id><pub-id pub-id-type="pmid">17551044</pub-id></citation></ref>
<ref id="b49-marinedrugs-09-00772"><label>49.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thiel</surname><given-names>V</given-names></name><name><surname>Neulinger</surname><given-names>SC</given-names></name><name><surname>Staufenberger</surname><given-names>T</given-names></name><name><surname>Schmaljohann</surname><given-names>R</given-names></name><name><surname>Imhoff</surname><given-names>JF</given-names></name></person-group><article-title>Spatial distribution of sponge-associated bacteria in the Mediterranean sponge <italic>Tethya aurantium</italic></article-title><source>FEMS Microbiol Ecol</source><year>2007</year><volume>59</volume><fpage>47</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6941.2006.00217.x</pub-id><pub-id pub-id-type="pmid">17059482</pub-id></citation></ref>
<ref id="b50-marinedrugs-09-00772"><label>50.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Basic Local alignment search tool</article-title><source>J Mol Biol</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">2231712</pub-id></citation></ref>
<ref id="b51-marinedrugs-09-00772"><label>51.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>JR</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Cardenas</surname><given-names>E</given-names></name><name><surname>Fish</surname><given-names>J</given-names></name><name><surname>Chai</surname><given-names>B</given-names></name><name><surname>Farris</surname><given-names>RJ</given-names></name><name><surname>Klam-Syed-Mohideen</surname><given-names>AS</given-names></name><name><surname>McCarell</surname><given-names>DM</given-names></name><name><surname>Marsh</surname><given-names>T</given-names></name><name><surname>Garrity</surname><given-names>GM</given-names></name><etal/></person-group><article-title>The Ribosoaml Database Project: Improved alignments and new tools for rRNA analysis</article-title><source>Nucl Acids Res</source><year>2009</year><volume>37</volume><fpage>D141</fpage><lpage>D145</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn879</pub-id><pub-id pub-id-type="pmid">19004872</pub-id></citation></ref>
<ref id="b52-marinedrugs-09-00772"><label>52.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>JD</given-names></name><name><surname>Gibson</surname><given-names>TJ</given-names></name><name><surname>Plewniak</surname><given-names>F</given-names></name><name><surname>Jeanmougin</surname><given-names>F</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name></person-group><article-title>The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality tools</article-title><source>Nucl Acid Res</source><year>1997</year><volume>25</volume><fpage>4876</fpage><lpage>4882</lpage><pub-id pub-id-type="doi">10.1093/nar/25.24.4876</pub-id></citation></ref>
<ref id="b53-marinedrugs-09-00772"><label>53.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashenafi</surname><given-names>M</given-names></name><name><surname>Carrington</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>AC</given-names></name><name><surname>Byrnes</surname><given-names>WM</given-names></name></person-group><article-title>The fused TrpEG from <italic>Streptomyces venezuelae</italic> is an anthranilate synthase, not an 2-amino-4-deoxyisochorismate (ADIC) synthase</article-title><source>Ethn Dis</source><year>2008</year><volume>18</volume><issue>Suppl. 2</issue><fpage>S2–S9–13</fpage></citation></ref>
<ref id="b54-marinedrugs-09-00772"><label>54.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weisburg</surname><given-names>WG</given-names></name><name><surname>Barns</surname><given-names>SM</given-names></name><name><surname>Pelletier</surname><given-names>DA</given-names></name><name><surname>Lane</surname><given-names>DJ</given-names></name></person-group><article-title>16S ribosomal DNA amplification for phylogenetic study</article-title><source>J Bacteriol</source><year>1991</year><volume>173</volume><fpage>697</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">1987160</pub-id></citation></ref>
<ref id="b55-marinedrugs-09-00772"><label>55.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muyzer</surname><given-names>G</given-names></name><name><surname>de Waal</surname><given-names>EC</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name></person-group><article-title>Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA</article-title><source>J Mol Biol</source><year>1993</year><volume>59</volume><fpage>695</fpage><lpage>700</lpage></citation></ref>
<ref id="b56-marinedrugs-09-00772"><label>56.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>EO</given-names></name><name><surname>Ward</surname><given-names>M</given-names></name><name><surname>Raney</surname><given-names>DE</given-names></name></person-group><article-title>Two simple media for the demonstration of pyocyanin and fluorescein</article-title><source>J Lab Clin Med</source><year>1954</year><volume>44</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">13184240</pub-id></citation></ref>
<ref id="b57-marinedrugs-09-00772"><label>57.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Laatsch</surname><given-names>H</given-names></name></person-group><source>Antibase 2007 SciDex: The Natural Products Identifier</source><edition>1st ed</edition><publisher-name>Wiley-VCH</publisher-name><publisher-loc>Weinheim, Germany</publisher-loc><year>2007</year></citation></ref>
<ref id="b58-marinedrugs-09-00772"><label>58.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Buckingham</surname><given-names>J</given-names></name></person-group><source>Dictionary of Natural Products on CD-ROM</source><edition>16.2 ed</edition><publisher-name>Chapman and Hall</publisher-name><publisher-loc>London, UK</publisher-loc><year>2008</year></citation></ref>
<ref id="b59-marinedrugs-09-00772"><label>59.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laursen</surname><given-names>JB</given-names></name><name><surname>Nielsen</surname><given-names>J</given-names></name></person-group><article-title>Phenazine natural products: Biosynthesis, synthetic analogues, and biological activity</article-title><source>Chem Rev</source><year>2004</year><volume>104</volume><fpage>1663</fpage><lpage>1686</lpage><pub-id pub-id-type="pmid">15008629</pub-id></citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures and Tables</title>
<fig id="f1-marinedrugs-09-00772" position="float">
<label>Figure 1.</label>
<caption>
<p>Schematic representation of the phenazine biosynthesis pathway.</p></caption>
<graphic xlink:href="marinedrugs-09-00772f1.gif"/></fig>
<fig id="f2-marinedrugs-09-00772" position="float">
<label>Figure 2.</label>
<caption>
<p>Alignment of known <italic>phz</italic>E gene sequences. Marked blocks served as the basis for primer construction.</p></caption>
<graphic xlink:href="marinedrugs-09-00772f2.gif"/></fig>
<fig id="f3-marinedrugs-09-00772" position="float">
<label>Figure 3.</label>
<caption>
<p><italic>Phz</italic>E gene fragment amplification of selected strains. Lane 1 and 10: 1 kb DNA-ladder; 2: positive control <italic>Pseudomonas chlororaphis</italic> subsp. <italic>chlororaphis</italic> DSM 50083<sup>T</sup>; 3: negative control (without template DNA); 4, 5, and 6: isolates H253, HB117, and LB129, respectively, exhibiting <italic>phz</italic>E fragments; 7, 8, and 9: isolates HB290, HB147, and LB164, respectively, exhibiting nor <italic>phz</italic>E fragments.</p></caption>
<graphic xlink:href="marinedrugs-09-00772f3.gif"/></fig>
<fig id="f4-marinedrugs-09-00772" position="float">
<label>Figure 4.</label>
<caption>
<p><bold>(a)</bold> UV/MS-chromatogram (black line: MS; green line: UV at 250 nm) of a 17 day-old GYM agar plate of strain <italic>Streptomyces cinnamonensis</italic> DSM 1042<sup>T</sup>. Endophenazine A-C, phenazine-1-carboxylic acid, phenazine-1,6-dicarboxylic acid and an unknown phenazine substance were detected as well as naphterpin and furanonaphthachinon I; <bold>(b)</bold> UV/MS-chromatogram (black line: MS; green line: UV at 250 nm) of a 17 day-old GYM agar plate of <italic>Streptomyces</italic> strain LB129. 1-carboxymethyl phenazine and phencomycin methyl ester were detected; <bold>(c)</bold> UV/MS-chromatogram (black line: MS; green line: UV at 250 nm) of a 17 day-old GYM agar plate of strain HB202. Different streptophenazines and the aromatic polyketide mayamycin were detected.</p></caption>
<graphic xlink:href="marinedrugs-09-00772f4.gif"/></fig>
<fig id="f5-marinedrugs-09-00772" position="float">
<label>Figure 5.</label>
<caption>
<p>Structures of selected phenazines produced by <italic>Pseudomonas chlororaphis</italic> subsp. <italic>chlororaphis</italic> DSM 50083<sup>T</sup> and <italic>Streptomyces cinnamonensis</italic> DSM 1042<sup>T</sup>.</p></caption>
<graphic xlink:href="marinedrugs-09-00772f5.gif"/></fig>
<table-wrap id="t1-marinedrugs-09-00772" position="float">
<label>Table 1.</label>
<caption>
<p>Distribution of <italic>phz</italic>E phenazine genes among major phylogenetic groups and phenazine production of cultures (number of strains).</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="2"><bold>Phylogenetic group</bold></th>
<th colspan="3" align="center" valign="middle"><bold>Number of strains</bold>
<hr/></th></tr>
<tr>
<th align="center" valign="middle"><bold>Analyzed</bold></th>
<th align="left" valign="middle"><bold>PCR amplification <italic>phz</italic>E gene positive</bold></th>
<th align="left" valign="middle"><bold>Producing phenazines in culture</bold></th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top"><italic>Actinobacteria</italic><xref ref-type="table-fn" rid="tfn1-marinedrugs-09-00772"><sup>a</sup></xref></td>
<td align="center" valign="middle">76</td>
<td align="center" valign="middle">11</td>
<td align="center" valign="middle">11</td></tr>
<tr>
<td align="left" valign="top"><italic>Bacteroidetes</italic></td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td></tr>
<tr>
<td align="left" valign="top"><italic>Firmicutes</italic></td>
<td align="center" valign="middle">28</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">0</td></tr>
<tr>
<td align="left" valign="top"><italic>Alphaproteobacteria</italic></td>
<td align="center" valign="middle">21</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">0</td></tr>
<tr>
<td align="left" valign="top"><italic>Betaproteobacteria</italic></td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0</td></tr>
<tr>
<td align="left" valign="top"><italic>Gammaproteobacteria</italic><xref ref-type="table-fn" rid="tfn2-marinedrugs-09-00772"><sup>b</sup></xref></td>
<td align="center" valign="middle">39</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">3</td></tr>
<tr>
<td align="left" valign="top"><bold>In total</bold></td>
<td align="center" valign="middle"><bold>168</bold></td>
<td align="center" valign="middle"><bold>17</bold></td>
<td align="center" valign="middle"><bold>14</bold></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-marinedrugs-09-00772">
<label>a</label>
<p>including control strain <italic>S. cinnamonensis.</italic></p></fn><fn id="tfn2-marinedrugs-09-00772">
<label>b</label>
<p>including 3 control <italic>P. chlororaphis</italic> strains.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t2-marinedrugs-09-00772" position="float">
<label>Table 2.</label>
<caption>
<p>Presence of phenazine biosynthesis genes in the strains investigated. Information on related type strains (according to 16S rRNA sequences) and sequence similarity of <italic>phz</italic>E genes to known phenazine genes is displayed. Length, similarity and original bearer of the genetic information of the <italic>phz</italic>E PCR products are also included.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top"><bold>Strain no.</bold></th>
<th align="left" valign="top"><bold>Next relative type strain and acc.-no.</bold><xref ref-type="table-fn" rid="tfn3-marinedrugs-09-00772"><italic><sup>a</sup></italic></xref></th>
<th align="left" valign="top"><bold>Phylum</bold><xref ref-type="table-fn" rid="tfn3-marinedrugs-09-00772"><italic><sup>b</sup></italic></xref></th>
<th align="center" valign="top"><bold>Sequence length</bold><italic><xref ref-type="table-fn" rid="tfn4-marinedrugs-09-00772"><sup>c</sup></xref></italic></th>
<th align="left" valign="top"><bold>Related phenazine gene, acc.-no.</bold><italic><xref ref-type="table-fn" rid="tfn5-marinedrugs-09-00772"><sup>d</sup></xref></italic><bold>, similarity and producer</bold></th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Strains used as DSM 1042<sup>T</sup></td>
<td align="left" valign="top">Positive control<break/><italic>Streptomyces cinnamonensis</italic> DSM 1042<sup>T</sup>; DQ462657</td>
<td align="left" valign="top"><break/>A</td>
<td align="left" valign="top"><break/>127</td>
<td align="left" valign="top"><break/><italic>phz</italic>E; CAL34110; 100%; <italic>S. cinnamonenis</italic></td></tr>
<tr>
<td align="left" valign="top">DSM 6698<sup>T</sup></td>
<td align="left" valign="top"><italic>Pseudomonas chlororaphis</italic> subsp. <italic>aureofaciens</italic> DSM 6698<sup>T</sup>; AY509898</td>
<td align="left" valign="top">GP</td>
<td align="left" valign="top">139</td>
<td align="left" valign="top"><italic>phz</italic>E: ADP21173; 100% <italic>P. chlororaphis</italic><break/><italic>phz</italic>F: ADP21174; 100% <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">DSM 19603<sup>T</sup></td>
<td align="left" valign="top"><italic>Pseudomonas chlororaphis</italic> subsp. <italic>aurantiaca</italic> DSM 19603<sup>T</sup>; DQ682655</td>
<td align="left" valign="top">GP</td>
<td align="left" valign="top">137</td>
<td align="left" valign="top"><italic>phz</italic>E: ADP21173; 98% <italic>P. chlororaphis</italic><break/><italic>phz</italic>F: ADP21174 49% <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">DSM 50083<sup>T</sup></td>
<td align="left" valign="top"><italic>Pseudomonas chlororaphis</italic> subsp. <italic>chlororaphis</italic> DSM 50083<sup>T</sup>; Z76673</td>
<td align="left" valign="top">GP</td>
<td align="left" valign="top">125</td>
<td align="left" valign="top"><italic>phz</italic>E; AAF17499; 92% <italic>P. chlororaphis</italic><break/><italic>phz</italic>F: AAF17500; 99% <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">Environmental</td>
<td align="left" valign="top">Isolates</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
<td align="left" valign="top"/></tr>
<tr>
<td align="left" valign="top">AB108</td>
<td align="left" valign="top"><italic>Pseudovibrio ascidiaceicola</italic> F423<sup>T</sup>; AB175663</td>
<td align="left" valign="top">AP</td>
<td align="left" valign="top">144</td>
<td align="left" valign="top"><italic>phz</italic>E; CAL34110; 95%; <italic>S. cinnamonenis</italic></td></tr>
<tr>
<td align="left" valign="top">HB117</td>
<td align="left" valign="top"><italic>Streptomyces fulvorobeus</italic> LMG 19901<sup>T</sup>; AJ781331</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">141</td>
<td align="left" valign="top"><italic>phz</italic>E; AAF17499; 73%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">HB122</td>
<td align="left" valign="top"><italic>Streptomyces luridiscabiei</italic> S63<sup>T</sup> AF361784</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">141</td>
<td align="left" valign="top"><italic>phz</italic>E; AAF17499; 74%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">HB202</td>
<td align="left" valign="top"><italic>Streptomyces mediolani</italic> LMG 20093<sup>T</sup>; AJ781354</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">91</td>
<td align="left" valign="top"><italic>phz</italic>E; NP_252903; 84%; <italic>P. aeruginosa</italic></td></tr>
<tr>
<td align="left" valign="top">HB253</td>
<td align="left" valign="top"><italic>Micromonospora matsumotoense</italic> IMSNU 22003<sup>T</sup>; AF152109</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">144</td>
<td align="left" valign="top"><italic>phz</italic>B; AAF17496; 67%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">HB254</td>
<td align="left" valign="top"><italic>Micromonospora matsumotoense</italic> IMSNU 22003<sup>T</sup>; AF152109</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">140</td>
<td align="left" valign="top"><italic>phz</italic>E; AAF17499; 73%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">HB291</td>
<td align="left" valign="top"><italic>Streptomyces fulvorobeus</italic> LMG 19901<sup>T</sup>; AJ781331</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">140</td>
<td align="left" valign="top"><italic>phz</italic>E; AAF17499; 73%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">LB066</td>
<td align="left" valign="top"><italic>Kiloniella laminariae</italic> LD81<sup>T</sup>; AM749667</td>
<td align="left" valign="top">AL</td>
<td align="left" valign="top">132</td>
<td align="left" valign="top"><italic>phz</italic>E; CAL34110; 91%; <italic>S. cinnamonenis</italic></td></tr>
<tr>
<td align="left" valign="top">LB114</td>
<td align="left" valign="top"><italic>Streptomyces flavogriseus</italic> DSM 40323<sup>T</sup>; AJ494864</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">141</td>
<td align="left" valign="top"><italic>phz</italic>E; AAF17499; 79%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">LB129</td>
<td align="left" valign="top"><italic>Streptomyces fimicarius</italic> ISP 5322<sup>T</sup>; AY999784</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">145</td>
<td align="left" valign="top"><italic>phz</italic>B; AAF17496; 75%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">LB150</td>
<td align="left" valign="top"><italic>Streptomyces luridiscabiei</italic> S63<sup>T</sup>; AF361784</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">132</td>
<td align="left" valign="top"><italic>phz</italic>B; AAF17496; 74%; <italic>P. chlororaphis</italic></td></tr>
<tr>
<td align="left" valign="top">LB151</td>
<td align="left" valign="top"><italic>Streptomyces griseus</italic> ATCC51928<sup>T</sup>; AF112160</td>
<td align="left" valign="top">A</td>
<td align="left" valign="top">133</td>
<td align="left" valign="top"><italic>phz</italic>E; AAF17499; 65%; <italic>P. chlororaphis</italic></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn3-marinedrugs-09-00772">
<p><italic><sup>a</sup></italic> NCBI accession number. (all sequences were at least 98.5% similar to the corresponding type strain).</p></fn><fn id="tfn4-marinedrugs-09-00772">
<label><italic><sup>b</sup></italic></label>
<p>A = <italic>Actinobacteria</italic>, AP = <italic>Alphaproteobacteria</italic>, GP = <italic>Gammaproteobacteria,</italic> F = <italic>Firmicutes</italic>.</p></fn><fn id="tfn5-marinedrugs-09-00772">
<label><italic><sup>c</sup></italic></label>
<p>Given is the number of amino acids.</p></fn><fn id="tfn6-marinedrugs-09-00772">
<label><italic><sup>d</sup></italic></label>
<p>NCBI accession number.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t3-marinedrugs-09-00772" position="float">
<label>Table 3.</label>
<caption>
<p>Known and putative novel phenazines from the strains studied.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top"><bold>Strain no.</bold></th>
<th align="left" valign="top"><bold>Next relative type strain</bold></th>
<th align="left" valign="top"><bold>[M<sup>+</sup>]</bold></th>
<th align="left" valign="top"><bold>UV absorption maxima (nm)</bold><xref ref-type="table-fn" rid="tfn7-marinedrugs-09-00772"><italic><sup>a</sup></italic></xref></th>
<th align="left" valign="top"><bold>Dereplication of phenazines</bold></th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="8">Strains used as DSM 1042<sup>T</sup></td>
<td align="left" valign="top">positive control<break/><italic>Streptomyces cinnamonensis</italic> DSM 1042<sup>T</sup></td>
<td align="left" valign="top"><break/>206</td>
<td align="left" valign="top"><break/>327, 249, 212</td>
<td align="left" valign="top"><break/>no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">224</td>
<td align="left" valign="top">371, 249, 215</td>
<td align="left" valign="top">phenazine-1-carboxylic acid [<xref ref-type="bibr" rid="b41-marinedrugs-09-00772">41</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">268</td>
<td align="left" valign="top">375, 256, 223</td>
<td align="left" valign="top">phenazine-1,6-dicarboxylic acid [<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">292</td>
<td align="left" valign="top">371, 254, 214</td>
<td align="left" valign="top">endophenazine A [<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>] <xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><italic><sup>c</sup></italic></xref></td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">306</td>
<td align="left" valign="top">387, 269, 211</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">308</td>
<td align="left" valign="top">372, 249, 212</td>
<td align="left" valign="top">endophenazine C [<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">322</td>
<td align="left" valign="top">375, 256, 223</td>
<td align="left" valign="top">endophenazine B [<xref ref-type="bibr" rid="b15-marinedrugs-09-00772">15</xref>]<xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><italic><sup>c</sup></italic></xref></td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">336</td>
<td align="left" valign="top">372, 249, 212</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top" rowspan="2">DSM 6698<sup>T</sup></td>
<td align="left" valign="top" rowspan="2"><italic>Pseudomonas chlororaphis</italic> subsp. <italic>aureofaciens</italic> DSM 6698<sup>T</sup></td>
<td align="left" valign="top">196</td>
<td align="left" valign="top">368, 257, 219</td>
<td align="left" valign="top">2-hydroxy-phenazine [<xref ref-type="bibr" rid="b42-marinedrugs-09-00772">42</xref>]</td></tr>
<tr>
<td align="left" valign="top">224</td>
<td align="left" valign="top">371, 249, 215</td>
<td align="left" valign="top">phenazine-1-carboxylic acid [<xref ref-type="bibr" rid="b41-marinedrugs-09-00772">41</xref>]</td></tr>
<tr>
<td align="left" valign="top" rowspan="2">DSM 19603 <sup>T</sup></td>
<td align="left" valign="top" rowspan="2"><italic>Pseudomonas chlororaphis</italic> subsp. <italic>aurantiaca</italic> DSM 19603<sup>T</sup></td>
<td align="left" valign="top">196</td>
<td align="left" valign="top">368, 257, 219</td>
<td align="left" valign="top">2-hydroxy-phenazine [<xref ref-type="bibr" rid="b42-marinedrugs-09-00772">42</xref>]<xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><sup>c</sup></xref></td></tr>
<tr>
<td align="left" valign="top">224</td>
<td align="left" valign="top">371, 249, 215</td>
<td align="left" valign="top">phenazine-1-carboxylic acid [<xref ref-type="bibr" rid="b41-marinedrugs-09-00772">41</xref>]<xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><sup>c</sup></xref></td></tr>
<tr>
<td align="left" valign="top">DSM 50083 <sup>T</sup></td>
<td align="left" valign="top"><italic>Pseudomonas chlororaphis</italic> subsp. <italic>chlororaphis</italic> DSM 50083<sup>T</sup></td>
<td align="left" valign="top">223</td>
<td align="left" valign="top">370, 248, 213</td>
<td align="left" valign="top">chlororaphin [<xref ref-type="bibr" rid="b43-marinedrugs-09-00772">43</xref>]</td></tr>
<tr>
<td align="left" valign="top">Environmental</td>
<td align="left" valign="top">Isolates</td>
<td align="left" valign="top"/>
<td align="left" valign="top"/>
<td align="left" valign="top"/></tr>
<tr>
<td align="left" valign="top" rowspan="2">HB117</td>
<td align="left" valign="top" rowspan="2"><italic>Streptomyces fulvorobeus</italic> LMG 19901<sup>T</sup></td>
<td align="left" valign="top">494</td>
<td align="left" valign="top">370(br), 274, 224</td>
<td align="left" valign="top">Senacarcin A</td></tr>
<tr>
<td align="left" valign="top">512</td>
<td align="left" valign="top">370(br), 275, 230</td>
<td align="left" valign="top">saphenyl ester D [<xref ref-type="bibr" rid="b29-marinedrugs-09-00772">29</xref>]</td></tr>
<tr>
<td align="left" valign="top" rowspan="6">HB122</td>
<td align="left" valign="top"><italic>Streptomyces luridiscabiei</italic> S63<sup>T</sup></td>
<td align="left" valign="top">492</td>
<td align="left" valign="top">376, 275, 235sh</td>
<td align="left" valign="top">saphenyl ester D [<xref ref-type="bibr" rid="b29-marinedrugs-09-00772">29</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">496</td>
<td align="left" valign="top">438sh, 383(br), 276, 227</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">498</td>
<td align="left" valign="top">419sh, 393-325, 289, 253sh, 220</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">508</td>
<td align="left" valign="top">376, 275, 235sh</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">510</td>
<td align="left" valign="top">430(br), 325, 224</td>
<td align="left" valign="top">derivative of aestivophoenin C [<xref ref-type="bibr" rid="b44-marinedrugs-09-00772">44</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">512</td>
<td align="left" valign="top">432(br), 327, 226</td>
<td align="left" valign="top">aestivophoenin C [<xref ref-type="bibr" rid="b44-marinedrugs-09-00772">44</xref>]</td></tr>
<tr>
<td align="left" valign="top" rowspan="8">HB202</td>
<td align="left" valign="top"><italic>Streptomyces mediolani</italic> LMG 20093<sup>T</sup></td>
<td align="left" valign="top">396</td>
<td align="left" valign="top">368, 364sh, 351sh, 252, 218</td>
<td align="left" valign="top">streptophenazines E [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]<xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><italic><sup>c</sup></italic></xref></td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">410</td>
<td align="left" valign="top">371, 364sh, 354sh, 252, 213</td>
<td align="left" valign="top">streptophenazines C [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">410</td>
<td align="left" valign="top">368, 364sh, 351sh. 252, 218</td>
<td align="left" valign="top">streptophenazines D [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]<xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><italic><sup>c</sup></italic></xref></td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">424</td>
<td align="left" valign="top">367, 363sh, 350sh, 252, 215</td>
<td align="left" valign="top">streptophenazines A [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">424</td>
<td align="left" valign="top">368, 364sh, 351sh, 252, 218</td>
<td align="left" valign="top">streptophenazines B [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]<xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><italic><sup>c</sup></italic></xref></td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">438</td>
<td align="left" valign="top">368, 364sh, 353sh, 252, 215</td>
<td align="left" valign="top">streptophenazines F [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]<xref ref-type="table-fn" rid="tfn9-marinedrugs-09-00772"><italic><sup>c</sup></italic></xref></td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">438</td>
<td align="left" valign="top">368, 363sh, 351sh, 252, 214</td>
<td align="left" valign="top">streptophenazines G [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">440</td>
<td align="left" valign="top">368, 363sh, 352sh, 252, 215</td>
<td align="left" valign="top">streptophenazines H [<xref ref-type="bibr" rid="b39-marinedrugs-09-00772">39</xref>]</td></tr>
<tr>
<td align="left" valign="top" rowspan="3">HB253</td>
<td align="left" valign="top" rowspan="3"><italic>Micromonospora matsumotoense</italic> IMSNU 22003<sup>T</sup></td>
<td align="left" valign="top">260</td>
<td align="left" valign="top">458, 302sh, 261, 232</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top">465</td>
<td align="left" valign="top">362sh, 345, 299, 221</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top">566</td>
<td align="left" valign="top">362sh, 345, 299, 221</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top">HB254</td>
<td align="left" valign="top"><italic>Micromonospora matsumotoense</italic> IMSNU 22003<sup>T</sup></td>
<td align="left" valign="top">451</td>
<td align="left" valign="top">361, 343, 352, 301, 223</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top" rowspan="6">HB291</td>
<td align="left" valign="top"><italic>Streptomyces fulvorobeus</italic> LMG 19901<sup>T</sup></td>
<td align="left" valign="top">492</td>
<td align="left" valign="top">376, 275, 235sh</td>
<td align="left" valign="top">saphenyl ester D [<xref ref-type="bibr" rid="b29-marinedrugs-09-00772">29</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">496</td>
<td align="left" valign="top">438sh, 383(br), 276, 227</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">498</td>
<td align="left" valign="top">419sh, 393-325, 289, 253sh, 220</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">508</td>
<td align="left" valign="top">376, 275, 235sh</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">510</td>
<td align="left" valign="top">430(br), 325, 224</td>
<td align="left" valign="top">derivative of aestivophoenin C [<xref ref-type="bibr" rid="b44-marinedrugs-09-00772">44</xref>]</td></tr>
<tr>
<td align="left" valign="top"/>
<td align="left" valign="top">512</td>
<td align="left" valign="top">432(br), 327, 226</td>
<td align="left" valign="top">aestivophoenin C [<xref ref-type="bibr" rid="b44-marinedrugs-09-00772">44</xref>]</td></tr>
<tr>
<td align="left" valign="top" rowspan="2">LB114</td>
<td align="left" valign="top" rowspan="2"><italic>Streptomyces flavogriseus</italic> DSM 40323<sup>T</sup></td>
<td align="left" valign="top">n.d.<xref ref-type="table-fn" rid="tfn8-marinedrugs-09-00772"><italic><sup>b</sup></italic></xref></td>
<td align="left" valign="top">370, 270, 244</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top">n.d.<xref ref-type="table-fn" rid="tfn8-marinedrugs-09-00772"><italic><sup>b</sup></italic></xref></td>
<td align="left" valign="top">419, 367, 305, 228</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top" rowspan="2">LB129</td>
<td align="left" valign="top" rowspan="2"><italic>Streptomyces fimicarius</italic> ISP 5322<sup>T</sup></td>
<td align="left" valign="top">296</td>
<td align="left" valign="top">366, 249, 214</td>
<td align="left" valign="top">phencomycin methyl ester [<xref ref-type="bibr" rid="b9-marinedrugs-09-00772">9</xref>]</td></tr>
<tr>
<td align="left" valign="top">238</td>
<td align="left" valign="top">366, 249, 214</td>
<td align="left" valign="top">1-carboxymethyl phenazine</td></tr>
<tr>
<td align="left" valign="top">LB150</td>
<td align="left" valign="top"><italic>Streptomyces luridiscabiei</italic> S63<sup>T</sup></td>
<td align="left" valign="top">510</td>
<td align="left" valign="top">sh401, 378, 274, 227</td>
<td align="left" valign="top">no hit in database</td></tr>
<tr>
<td align="left" valign="top">LB151</td>
<td align="left" valign="top"><italic>Streptomyces griseus</italic> ATCC 51928<sup>T</sup></td>
<td align="left" valign="top">510</td>
<td align="left" valign="top">sh401, 378, 274, 227</td>
<td align="left" valign="top">no hit in database</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn7-marinedrugs-09-00772">
<label><italic><sup>a</sup></italic></label>
<p>sh, shoulder, br, broad.</p></fn><fn id="tfn8-marinedrugs-09-00772">
<label><italic><sup>b</sup></italic></label>
<p>n.d., not detectable.</p></fn><fn id="tfn9-marinedrugs-09-00772">
<label><italic><sup>c</sup></italic></label>
<p>substance was isolated by prepHPLC and structure was identified by UV-MS and <sup>1</sup>H NMR analysis (data not shown).</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t4-marinedrugs-09-00772" position="float">
<label>Table 4.</label>
<caption>
<p>Primers used in this study.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle"><bold>Primer</bold></th>
<th align="left" valign="middle"><bold>Sequence</bold></th>
<th align="left" valign="middle"><bold>Function</bold></th>
<th align="left" valign="middle"><bold>Ref.</bold></th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">27f</td>
<td align="left" valign="middle">5′-GAGTTTGATCCTGGCTCAG-3′</td>
<td align="left" valign="middle">PCR of the 16S rRNA gene</td>
<td align="left" valign="middle">[<xref ref-type="bibr" rid="b54-marinedrugs-09-00772">54</xref>]</td></tr>
<tr>
<td align="left" valign="top">1492r</td>
<td align="left" valign="middle">5′-GGTTACCTTGTTACGACTT-3′</td>
<td align="left" valign="middle">PCR of the 16S rRNA gene</td>
<td align="left" valign="middle">[<xref ref-type="bibr" rid="b54-marinedrugs-09-00772">54</xref>]</td></tr>
<tr>
<td align="left" valign="top">534r</td>
<td align="left" valign="middle">5′-ATTACCGCGGCTGCTGG-3′</td>
<td align="left" valign="middle">Sequencing of the 16S rRNA gene</td>
<td align="left" valign="middle">[<xref ref-type="bibr" rid="b55-marinedrugs-09-00772">55</xref>]</td></tr>
<tr>
<td align="left" valign="top">342f</td>
<td align="left" valign="middle">5′-TACGGGAGGCAGCAG-3′</td>
<td align="left" valign="middle">sequencing of the 16S rRNA gene</td>
<td align="left" valign="middle">[<xref ref-type="bibr" rid="b55-marinedrugs-09-00772">55</xref>]</td></tr>
<tr>
<td align="left" valign="top">790f</td>
<td align="left" valign="middle">5′-GATACCCTGGTAGTCC-3′</td>
<td align="left" valign="middle">sequencing of the 16S rRNA gene</td>
<td align="left" valign="middle">[<xref ref-type="bibr" rid="b50-marinedrugs-09-00772">50</xref>]</td></tr>
<tr>
<td align="left" valign="top"><italic>phz</italic>Ef</td>
<td align="left" valign="middle">5′-GAAGGCGCCAACTTCGTYATCAA-3′</td>
<td align="left" valign="middle">PCR and sequencing of <italic>phz</italic>E gene</td>
<td align="left" valign="middle">this study</td></tr>
<tr>
<td align="left" valign="top"><italic>phz</italic>Er</td>
<td align="left" valign="middle">5′-GCCYTCGATGAAGTACTCGGTGTG-3′</td>
<td align="left" valign="middle">PCR and sequencing of <italic>phz</italic>E gene</td>
<td align="left" valign="middle">this study</td></tr>
<tr>
<td align="left" valign="top">Ps_up1</td>
<td align="left" valign="middle">5′-ATCTTCACCCCGGTCAACG-3′</td>
<td align="left" valign="middle">PCR and sequencing of <italic>phz</italic>F gene</td>
<td align="left" valign="middle">[<xref ref-type="bibr" rid="b21-marinedrugs-09-00772">21</xref>]</td></tr>
<tr>
<td align="left" valign="top">Ps_low1</td>
<td align="left" valign="middle">5′-CCRTAGGCCGGTGAGAAC-3′</td>
<td align="left" valign="middle">PCR and sequencing of <italic>phz</italic>F gene</td>
<td align="left" valign="middle">[<xref ref-type="bibr" rid="b21-marinedrugs-09-00772">21</xref>]</td></tr></tbody></table></table-wrap></sec></back></article>
